References
- 1. ÅSHILD FARESJÖ,EWA GRODZINSKY,CLAES HALLERT, TOOMAS TIMPKA. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care. BMC Public Health 2013, 13:832 http://www.biomedcentral.com/1471-2458/13/832.
- 2. DEVANARAYANA NM, METTANANDA S, LIYANARACHCHI C, NANAYAKKARA N, MENDIS N, PERERA N, RAJINDRAJITH S. Abdominal pain-predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress. J Pediatr Gastroenterol Nutr, 2011, 53:659-665.
- 3. ZHOU H, YAO M, CHENG G-Y, CHEN Y-P, LI D-G. Prevalence and associated factors of functional gastrointestinal disorders and bowel habits in Chinese adolescents: a school-based study. J Pediatr Gastroenterol Nutr2011, 53:168-173.
- 4. 4. RUTTEN JM,VLIEGER AM,FRANKENHUIS C,GEORGE EK,GROENEWEG M,NORBRUIS OF,TJON A TEN W,VAN WERING H,DIJKGRAAF MG,MERKUS MP,BENNINGA MA. Gut-directed hypnotherapy in children with irritable bowel syndrome or functional abdominal pain (syndrome): a randomized controlled trial on self exercises at home using CD versus individual therapy by qualified therapists. BMC Pediatr. 2014 Jun 4;14:140. doi: 10.1186/1471-2431-14-140.
- 5. CHOUNG RS, LOCKE GR III. Epidemiology of IBS.Gastroenterol. Clin North Am 2011, 40:1-10.
- 6. HERSCHBACH P, HENRICH G, VON RAD M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behaviour? Psychosom Med 1999, 61:148-153.
- 7. KOLOSKI NA, TALLEY NJ, BOYCE PM. Predictors of health care seeking for irritable bowel syndrome and non-ulcer dyspepsia: a critical review of the literature on symptoms and psychological factors. Am J Gastroenterol2001, 96:1340-1349.
- 8. VAN DULMEN AM, FENNIS JEM, MOKKINK HGA, VAN DER VELDEN HGM, BLEIJENBERG G. Doctor’s perceptions of patient’s cognitions and complaints in irritable bowel syndrome at an out-patients clinic. J Psychosom Res 1994, 38:581-590.
- 9. FARESJÖ Å, GRODZINSKY E, JOHANSSON S, WALLANDER MA, TIMPKA T, ÅKERLIND I. A population based case- control study of work and psychosocial problems in patients with irritable bowel syndrome-women are more seriously affected than men. Am J Gastroenterol 2007, 102(2):371-379.
- 10. HERSCHBACH P, HENRICH G, VON RAD M. Psychological factors in functional gastrointestinal disorders: characteristics of the disorder or of the illness behaviour? Psychosom Med 1999, 61:148-153.
- 11. TALLEY NJ, SPILLER R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet, 2002, 360:555-564.
- 12. MERTZ H, NALIBOFF B, MUNKATA J, NIAZI N, MAYER EA. Altered rectal perceptions are a biological marker of patients with irritable bowel syndrome. Gastroenterology, 1995, 109:40-52.
- 13. HEYMANN-MÖNNIKES I, ARNOLD R, FLORIN I, HERDA C, MELFSEN S, MÖNNIKES H. The combinations of medical treatment plus multicomponent behavioural therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol, 2000, 95:981-994.
- 14. GUTHRIE E, CREED F, DAWSON D, TOMENSON B. A randomized trial of psychotherapy in patients with refractory irritable bowel syndrome. Br. J Psychiatry, 1993, 163:315-321.
- 15. MARKOWITZ M, HARRIS W, RICCI JF, HARRISON C, GORDON SH, WENTZ A. Comorbid conditions in patients with irritable bowel syndrome: data from a national IBS awareness registry. Gastroenterology, 2001, 120 (SUPPL1):105.
- 16. HUDSON JI, GOLDENBERG DL, POPE HG, KECK PE, SCHLESINGER L. Co-morbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992, 92:363-367.
- 17. LONGSTRETH GF, WOLDE-TSADIK G. Irritable bowel-type symptoms in HMO examinees; prevalence, demographics, and clinical correlates. Dig Dis Sci1993, 38:1581-1589.
- 18. SPERBER AD, CARMEL S, ATZMON Y, WEISBERG I, SHALIT Y, NEUMAN L, FICH A, BUSKILA D. The sense of coherence index and the irritable bowel syndrome: a cross-sectional comparison among irritable bowel syndrome patients with and without coexisting fibromyalgia, irritable bowel syndrome non-patients, and controls. Scand J Gastroenterol, 1999, 34:259-263.
- 19. ÅSHILD FARESJÖ, EWA GRODZINSKY, CLAES HALLERT AND TOOMAS TIMPKA. Patients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls- eight years follow-up of IBS patients in primary care. BMC Public Health 2013, 13:832 doi:10.1186/1471-2458-13-832.
- 20. JONES R, LATIONOVIC J, CHARLTON J, GULLIFORD M. Psychical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the general practice research database. Aliment Pharmacol Ther, 2006, 24:879-886.
- 21. WHITHEAD WE, PALSSON O, JONES KR. Systematic review of the co-morbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology, 2002, 122:1140-1156.
- 22. MACLEAN EW, PALSSON OS, TURNER MJ, WHITEHEAD WE. Development and validation of new disease-specific measures of somatisation and co-morbidity in IBS. J Psychosom Res 2, 012, 73:352-355.
- 23. VANDVIK PO, LYDERSEN S, FARUP PG. Prevalence, co-morbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol, 2006, 41:650-656.
- 24. HAUG TANGEN T, MYKLETUN A, DAHL A. Are anxiety and depression related to gastrointestinal symptoms in the general populations? Scand J Gastroenterol, 2002, 37:294-298.
- 25. FARESJÖ Å, GRODZINSKY E, JOHANSSON S, WALLANDER MA, TIMPKA T, ÅKERLIND I. Psychosocial factors at work and in everyday life are associated with irritable bowel syndrome. Eur J Epidemiol, 2007, 22(7):473-480.
- 26. SPERBER AD, ATZMON Y, NEUMANN L, WEISBERG I, SHALIT Y, ABU-SHAKRAH M, FICH A, BUSKILA D. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gatroenterol, 1999, 94:3541-3546.
- 27. SLOTH H, JÖRGENSEN LS. Predictors for the course of chronic non-organic upper abdominal pain. Scand J Gastroenterol, 1989, 24:440-444.
- 28. VANDEVIK PO, WILHELMSEN I, IHLEBÄCK C, FARUP PG. Co-morbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther, 2004, 20:1195-1203.
- 29. CHANG F, LU CL. Irritable bowel syndrome and migraine; bystanders or partners? J Neurogastenterol Motil, 2013, 19:301-311.
- 30. AZPIROZ F, DAPOIGNY M, PACE F, MÜLLER-LISSNER S, COREMANS G, WHORWELL P, STOCKBRUGGER RW, SMOUT A. Nongastrointestinal disorders in the irritable bowel syndrome. Digestion, 2000, 62:66-72.
- 31. VANDEVIK PO, WILHELMSEN I, IHLEBÄCK C, FARUP PG. Co-morbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther, 2004, 20:1195-1203.